Pharmacokinetics of Low‐Dose Intravenous Pethidine in Patients with Renal Dysfunction
Authors:
- 1 July 1987
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 27 (7) , 516-522
Abstract
The kinetics and elimination of pethidine (meperidine) after intravenous administration (150 μg/kg) to ten healthy volunteer subjects were compared with those obtained from 18 patients who suffered from varying degrees of renal dysfunction. In both groups of subjects, pethidine was eliminated triexponentially from plasma. However, plasma concentrations in the patients (who were subdivided into patients with severe dysfunction, moderate dysfunction, and mild dysfunction) were consistently higher. The mean ± SEM elimination half‐life (t1/2) of pethidine was significantly longer in the three groups of renal patients: 7.9 ± 1.1, 20.2 ± 13.6, 16.6 ± 5.4, and 14.3 ± 3.1 hr, respectively, for healthy volunteers, patients with severe, moderate, and mild dysfunction; their mean ± SEM creatinine clearances were 97.3 ± 7.5, 1/2 of pethidine in renal patients may be attributable to a more extensive distribution of pethidine in the body (with a decrease in plasma protein binding) and a lower plasma clearance of the drugs.Keywords
This publication has 10 references indexed in Scilit:
- Analysis of meperidine and normeperidine in serum and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Clinical Pharmacokinetics of PethidineClinical Pharmacokinetics, 1982
- Meperidine disposition in man: Influence of urinary pH and route of administrationClinical Pharmacology & Therapeutics, 1981
- The effects of physicochemical properties of pethidine and its basic metabolites on their buccal absorption and renal eliminationJournal of Pharmacy and Pharmacology, 1979
- The current use of narcotic analgesics in hospital practice [proceedings]1979
- Accumulation of Normeperidine, an Active Metabolite of Meperidine, in Patients with Renal Failure or CancerAnnals of Internal Medicine, 1977
- The effect of ageing on plasma pethidine concentration.British Journal of Clinical Pharmacology, 1975
- Factors influencing the excretion and relative physiological availability of pethidine in manJournal of Pharmacy and Pharmacology, 1975
- Statistical estimations in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1974
- THE EXCRETION OF PETHIDINE AND ITS DERIVATIVESBritish Journal of Pharmacology and Chemotherapy, 1963